## Abstract Positron emission tomography (PET) using 18F‐2‐deoxy‐D‐glucose, a D‐glucose analog labeled with fluorine‐18, complements conventional radiologic assessment in the evaluation of patients with nonsmall‐cell lung cancer (NSCLC). PET is being routinely used to improve the detection of nodal
✦ LIBER ✦
Update in PET imaging of nonsmall cell lung cancer
✍ Scribed by Eric M Rohren; Val J Lowe
- Book ID
- 117822291
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 1006 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0001-2998
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Positron emission tomography imaging in
✍
Jeremy J. Erasmus; Homer A. Macapinlac; Stephen G. Swisher
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 537 KB
FDG-PET Imaging in Small Cell Lung Cance
✍
D Groshar; G.M Segall
📂
Article
📅
1999
🏛
Elsevier Science
🌐
English
⚖ 58 KB
Imaging: PET–CT imaging in non-small-cel
✍
Levine, Mark; Julian, Jim
📂
Article
📅
2009
🏛
Nature Publishing Group
🌐
English
⚖ 119 KB
Chemoradiation in advanced nonsmall cell
✍
Julianna Pisch; Anthony M. Berson; Stephen Malamud; Edward J. Beattie; James Har
📂
Article
📅
1995
🏛
Elsevier Science
🌐
English
⚖ 633 KB
Chemoradiation in advanced nonsmall cell
📂
Article
📅
1996
🏛
Elsevier Science
🌐
English
⚖ 134 KB
Predictive and prognostic value of FDG-P
✍
Lioe-Fee de Geus-Oei; Henricus F.M. van der Heijden; Frans H.M. Corstens; Wim J.
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 125 KB
👁 1 views
## Abstract For several years, molecular imaging with ^18^F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) has become part of the standard of care in presurgical staging of patients with nonsmall‐cell lung cancer (NSCLC), focusing on the detection of malignant lesions at early stages, ea